CN103599062B - A kind of eye cream and preparation method thereof - Google Patents
A kind of eye cream and preparation method thereof Download PDFInfo
- Publication number
- CN103599062B CN103599062B CN201310561265.4A CN201310561265A CN103599062B CN 103599062 B CN103599062 B CN 103599062B CN 201310561265 A CN201310561265 A CN 201310561265A CN 103599062 B CN103599062 B CN 103599062B
- Authority
- CN
- China
- Prior art keywords
- eye cream
- phase
- eye
- skin
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006071 cream Substances 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 16
- 239000007787 solid Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 32
- 235000006708 antioxidants Nutrition 0.000 abstract description 32
- 230000003078 antioxidant effect Effects 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 13
- 230000003020 moisturizing effect Effects 0.000 abstract description 8
- 239000000284 extract Substances 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 abstract description 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 235000021283 resveratrol Nutrition 0.000 abstract description 3
- 229940016667 resveratrol Drugs 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract description 2
- 229920002498 Beta-glucan Polymers 0.000 abstract description 2
- 244000197580 Poria cocos Species 0.000 abstract description 2
- 235000008599 Poria cocos Nutrition 0.000 abstract description 2
- 241001165494 Rhodiola Species 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract description 2
- 239000002932 luster Substances 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 239000004863 Frankincense Substances 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- 210000001747 pupil Anatomy 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 description 20
- 239000000243 solution Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 14
- 238000002835 absorbance Methods 0.000 description 12
- 239000000523 sample Substances 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000012085 test solution Substances 0.000 description 7
- 230000003712 anti-aging effect Effects 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 206010040954 Skin wrinkling Diseases 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000037336 dry skin Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- 235000019136 lipoic acid Nutrition 0.000 description 4
- 239000002516 radical scavenger Substances 0.000 description 4
- 229960002663 thioctic acid Drugs 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 229940123457 Free radical scavenger Drugs 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229940079877 pyrogallol Drugs 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 229940075000 frankincense extract Drugs 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- QXQAPNSHUJORMC-UHFFFAOYSA-N 1-chloro-4-propylbenzene Chemical compound CCCC1=CC=C(Cl)C=C1 QXQAPNSHUJORMC-UHFFFAOYSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000004266 EU approved firming agent Substances 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 230000001699 photocatalysis Effects 0.000 description 1
- 238000007146 photocatalysis Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- -1 siloxanes Chemical class 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
技术领域technical field
本发明主要涉及一种眼霜,属于化妆品领域。The invention mainly relates to an eye cream and belongs to the field of cosmetics.
背景技术Background technique
皮肤衰老是由内源性因素和外源性因素共同作用的结果。其中在机体代谢过程中产生的具有高度化学活性的自由基是衰老的重要启动因素。自由基是一种因失去一个电子而成的不对称、不稳定的原子或分子,具有很大的能量,可攻击细胞组织中的脂质、蛋白质、糖类和DNA等物质,企图夺取一个电子以求得重新平衡,这就造成了脂质和糖类的氧化、蛋白质的变性、酶的失活、DNA结构的切断、碱基变化等等,从而导致细胞膜、遗传因子等的损伤,进而诱发各种疾病、癌变、机体老化等。长期受紫外线照射、环境污染以及香烟烟雾等外源性因素也都会产生大量自由基,导致皮肤衰老。Skin aging is the result of the joint action of endogenous and exogenous factors. Among them, the highly chemically active free radicals produced in the body's metabolic process are important initiating factors of aging. Free radicals are asymmetric and unstable atoms or molecules formed by losing an electron. They have great energy and can attack lipids, proteins, sugars, DNA and other substances in cell tissues in an attempt to capture an electron. In order to achieve rebalancing, this causes the oxidation of lipids and sugars, denaturation of proteins, inactivation of enzymes, cutting of DNA structures, changes in bases, etc., resulting in damage to cell membranes, genetic factors, etc., and then induces Various diseases, cancer, body aging, etc. Exogenous factors such as long-term exposure to ultraviolet rays, environmental pollution, and cigarette smoke will also generate a large number of free radicals, leading to skin aging.
抗氧化剂可通过抑制自由基产生或清除和捕集自由基,使自由基链式反应中断而达到抗氧化目的。按其化学结构可分为酶类和非酶类抗氧化剂,酶类抗氧化剂包括超氧化歧化酶(SOD)、过氧化氢酶、辅酶Q10(CoQ10)和DNA/RNA修复酶等;非酶类抗氧化剂如维生素A(VA)、维生素C(VC)、维生素E(VE)、β-胡萝卜素、α-硫辛酸(LA)、谷胱甘肽(GSH)和锌、硒等物质。抗氧化剂用于化妆品中,既可抑制活性物质和营养成分在空气中经细菌侵入或光催化作用发生氧化变质,又可与化妆品中的其他活性成分共同发挥作用,起到保湿、除皱、抗衰老等功效。Antioxidants can achieve the purpose of anti-oxidation by inhibiting the generation of free radicals or scavenging and trapping free radicals, interrupting the chain reaction of free radicals. According to its chemical structure, it can be divided into enzymatic and non-enzymatic antioxidants. Enzymatic antioxidants include superoxide dismutase (SOD), catalase, coenzyme Q10 (CoQ10) and DNA/RNA repair enzymes, etc.; non-enzymatic Antioxidants such as vitamin A (VA), vitamin C (VC), vitamin E (VE), β-carotene, α-lipoic acid (LA), glutathione (GSH), zinc, selenium and other substances. Antioxidants are used in cosmetics, which can not only inhibit the oxidative deterioration of active substances and nutrients in the air through bacterial invasion or photocatalysis, but also work together with other active ingredients in cosmetics to moisturize, wrinkle, and anti-aging. effects of aging.
研究发现,某些复合抗氧化剂的抗氧化活性高于各组分在添加浓度下的活性之和,即多种抗氧化剂联合使用,其效果往往要大于使用同剂量的单一抗氧化剂的效果。抗氧化成分之间常具有抗氧化协同作用,且协同作用受抗氧化剂的浓度、反应体系等影响。美国加州大学伯克利分校著名教授、国际自由基学会主席LestPaker博士等学者提出了自由基清除剂链反应和抗氧化网络技术,清晰而明确地将它们比拟为高效抗衰老的现代最新模式。在此抗氧化剂体系或抗氧化剂网络中,VC、VE、CoQ10、LA、GSH被拟定为抗氧化网络技术的核心和本质,其原因主要有:第一,机体不能产生VC和VE,必须从食物中获得;第二,机体虽然可以自行产生GSH、LA和CoQ10,但它们在体内水平随着年龄增长而明显下降;第三,这5种抗氧化剂具有广谱、高效的自由基清除能力,且相互之间可以相互补充、协同增效;第四,网络自由基清除剂或网络抗氧化剂各有其不同于其它自由基清除剂或抗氧化剂的独特作用;第五,在体内这5种网络自由基清除剂或网络抗氧化剂之间存在相互作用,且能相互再生,使彼此进入再循环,形成了网络,极大地增强了抗氧化剂的功能,这个网络在生物体系中是抵御自由基介导的毒性损伤的主要防线,最终在延缓衰老和提高机体抗病能力的过程中发挥着特殊效用。Studies have found that the antioxidant activity of some composite antioxidants is higher than the sum of the activities of each component at the added concentration, that is, the combined use of multiple antioxidants is often greater than the effect of a single antioxidant at the same dose. Antioxidant components often have antioxidative synergistic effects, and the synergistic effect is affected by the concentration of antioxidants and the reaction system. Scholars such as Dr. Lest Paker, a famous professor at the University of California, Berkeley, and chairman of the International Free Radical Society, proposed the free radical scavenger chain reaction and antioxidant network technology, and clearly compared them to the latest modern and efficient anti-aging models. In this antioxidant system or antioxidant network, VC, VE, CoQ10, LA, and GSH are proposed as the core and essence of antioxidant network technology. The main reasons are as follows: First, the body cannot produce VC and VE, and must be obtained from food Second, although the body can produce GSH, LA and CoQ10 by itself, their levels in the body decrease significantly with age; third, these five antioxidants have broad-spectrum and high-efficiency free radical scavenging capabilities, and They can complement and synergize each other; fourth, network free radical scavengers or network antioxidants have their own unique effects that are different from other free radical scavengers or antioxidants; fifth, the five network free radicals in the body Radical scavengers or network antioxidants interact and can regenerate each other, allowing each other to recirculate, forming a network that greatly enhances the function of antioxidants. This network is mediated by free radicals in biological systems The main line of defense against toxic damage ultimately plays a special role in the process of delaying aging and improving the body's resistance to disease.
抗氧化链反应和抗氧化网络技术已成为目前国际上十分流行和创新的抗氧化、抗衰老现代模式。按照这种网络技术和模式,可以研制出各种不同类型的皮肤抗衰老化妆品,而5种抗氧化剂网络在抗衰老化妆品使用过程中一定会发挥积极作用和互补优势,使皮肤抗衰老表现出更明显的特色,产生更显著的效果。Antioxidant chain reaction and antioxidative network technology has become a very popular and innovative modern mode of antioxidation and antiaging in the world. According to this network technology and model, various types of skin anti-aging cosmetics can be developed, and the five antioxidant networks will definitely play an active role and complement each other in the use of anti-aging cosmetics, making the skin anti-aging more effective. Obvious features, produce more significant effect.
眼睛是心灵的窗户,也最能泄露女性的年龄。随着年龄的增长,眼部肌肤的烦恼会比脸上任何一个部位都多。眼部皮肤薄,脂肪含量少,缺乏弹性纤维和胶原结构,而频繁的眨眼又会使眼部肌肤受到不断的拉伸;加之生活作息不规律、用眼不当等都容易造成眼部皮肤暗淡、松弛,就会出现黑眼圈、眼袋、鱼尾纹等问题,而干性皮肤者更易出现上述衰老的迹象。眼霜主要针对干性皮肤者设计,比面霜更为清爽、细腻,既易于被眼部皮肤吸收,又能适当地补充油份,具有保湿、滋润、平复细纹等功效。Eyes are the windows to the soul, and they are the most revealing of a woman's age. As we age, the skin around the eyes suffers more than any other part of the face. The eye skin is thin, with low fat content, lack of elastic fibers and collagen structure, and frequent blinking will make the eye skin constantly stretched; coupled with irregular life and rest, improper use of eyes, etc., can easily cause eye skin to be dull, If the skin is loose, problems such as dark circles, bags under the eyes, and crow's feet will appear, and those with dry skin are more prone to the above-mentioned signs of aging. Eye cream is mainly designed for people with dry skin. It is more refreshing and delicate than face cream. It is easy to be absorbed by the eye skin and can properly replenish oil. It has the effects of moisturizing, moisturizing, and smoothing fine lines.
目前,市场上眼霜品种繁多,但尚未见将中草药提取物和抗氧化网络体系相结合应用到眼霜中的商品。本发明以抗氧化网络体系理论和乳化理论为指导,将多种具有抗氧化活性的添加剂及中草药提取物进行复配,同时添加高效保湿剂、紧肤剂,研制出具有保湿、抗皱、紧致等多重功效的眼霜;同时对该眼霜的感官和理化指标、保湿性、抗氧化性以及对眼周皮肤的抗皱紧致功效等进行测试。At present, there are many kinds of eye creams on the market, but there are no commercial products that combine Chinese herbal medicine extracts and antioxidant network systems into eye creams. Guided by the anti-oxidation network system theory and emulsification theory, the present invention compounded a variety of additives with anti-oxidation activity and Chinese herbal medicine extracts, and added high-efficiency moisturizing agents and skin-firming agents at the same time to develop a moisturizing, anti-wrinkle, and firming agent. and other multi-functional eye creams; at the same time, the sensory and physical and chemical indicators, moisturizing properties, antioxidant properties, and anti-wrinkle and firming effects on the skin around the eyes of the eye cream were tested.
发明内容Contents of the invention
本发明目的就是提供一种眼霜及其制备方法。The object of the present invention is to provide an eye cream and a preparation method thereof.
本发明是通过以下技术方案实现的:The present invention is achieved through the following technical solutions:
一种眼霜,其特征在于所述眼霜的配方为:A kind of eye cream, it is characterized in that the prescription of described eye cream is:
眼霜的制备方法:Preparation method of eye cream:
将A相和B相分别置于70-75℃水浴锅中搅拌25-30min,使固状物溶解,再将溶解好的F相加入到A相中使其分散均匀,然后边搅拌边把B相加入;快速搅拌25-30min后降温,冷却至40-45℃时将C相、D相及E相分别加入并搅拌至均匀,温度降至30-35℃时停止搅拌,出料,即得所述眼霜。Put phase A and phase B in a water bath at 70-75°C and stir for 25-30 minutes to dissolve the solids, then add the dissolved phase F to phase A to disperse evenly, and then dissolve phase B while stirring Add phases; stir rapidly for 25-30 minutes and then cool down. When cooled to 40-45°C, add phase C, phase D and phase E respectively and stir until uniform. When the temperature drops to 30-35°C, stop stirring and discharge to obtain The eye cream.
一种眼霜的制备方法,在制备过程中为使制成品总量保持为100g,在加入各个相的同时再加入适量的蒸馏水。The invention relates to a method for preparing an eye cream. In order to keep the total amount of the finished product at 100 g during the preparation process, an appropriate amount of distilled water is added while adding each phase.
本发明的优点是:The advantages of the present invention are:
本发明的眼霜以硅氧烷类、合成角鲨烷、辛酸/癸酸三甘油酯等为油相原料,滋润、滑爽、透气,赋予眼周肌肤如丝绸般的感觉;添加具有卓越补水能力的透明质酸钠、泛醇及燕麦β-葡聚糖等物质,可瞬间恢复皮肤的保湿及屏障功能,平衡调节肌肤的内在水循环并改善粗糙肤质;以抗氧化网络体系为中心,复配红景天提取物、白藜芦醇等活性较强的抗氧化剂,具有广谱、高效的自由基清除能力,且能协同增效,相互再生,使彼此进入再循环,极大地增强了抗氧化剂的功能;多糖紧肤剂抑制眼部松弛,让眼部肌肤塑型紧致,同时具有提高抵抗力,促进细胞增长,抗炎的效果;茯苓提取物能消水肿,提亮眼周;乳香提取物具有活血、抗炎、去除黑眼圈及紧致肌肤等功效;黄芪提取物能够促进胶原蛋白的合成;当归提取物可活血化瘀,有预防及去除黑眼圈的功效。The eye cream of the present invention uses siloxanes, synthetic squalane, caprylic acid/capric triglyceride, etc. as oil phase raw materials, which are moist, smooth, and breathable, and give the skin around the eyes a silky feeling; Sodium hyaluronate, panthenol and oat β-glucan and other substances can instantly restore the skin's moisturizing and barrier functions, balance and regulate the skin's internal water circulation and improve rough skin texture; centered on the antioxidant network system, the compound Rhodiola rosea extract, resveratrol and other active antioxidants have broad-spectrum and high-efficiency free radical scavenging capabilities, and can synergize, regenerate each other, and recycle each other, greatly enhancing the antioxidant capacity. function; polysaccharide firming agent inhibits eye relaxation, makes eye skin firm and firm, and at the same time has the effect of improving resistance, promoting cell growth, and anti-inflammation; Poria cocos extract can reduce edema and brighten the eye area; frankincense extract Herbs have the functions of promoting blood circulation, anti-inflammation, removing dark circles and firming the skin; Astragalus extract can promote the synthesis of collagen; Angelica extract can promote blood circulation and remove blood stasis, and has the effect of preventing and removing dark circles.
本发明的眼霜膏体细腻、色泽均匀。部分活性成分采用纳米乳液、脂质体和和微胶囊技术,既利于活性成分的传输及皮肤的吸收,又增加了产品的稳定性。配方中不含酒精、香精、尼泊金酯类,温和无刺激。多种活性成分相互配合,协同增效,可改善眼部皱纹、淡化黑眼圈、紧致眼周轮廓,令双眸回复奕奕神彩。The eye cream ointment of the present invention is fine and smooth, and color and luster are uniform. Some active ingredients adopt nanoemulsion, liposome and microcapsule technology, which not only facilitates the transmission of active ingredients and skin absorption, but also increases the stability of the product. The formula does not contain alcohol, fragrance, and parabens, and is mild and non-irritating. A variety of active ingredients cooperate with each other and synergistically, which can improve eye wrinkles, dilute dark circles, tighten the contours of the eyes, and restore the radiance of the eyes.
附图说明Description of drawings
图1为本发明眼霜样品的显微照片(×400);Fig. 1 is the photomicrograph (×400) of eye cream sample of the present invention;
图2为眼霜的吸湿率随时间变化关系图;Fig. 2 is the relationship diagram of the moisture absorption rate of eye cream as a function of time;
图3为试用者使用眼霜30分钟前后对比照片,(a)为使用前;(b)为使用15分钟后;(c)为使用30分钟后。Figure 3 is the comparison photos before and after the tester used the eye cream for 30 minutes, (a) before use; (b) after 15 minutes of use; (c) after 30 minutes of use.
图4为两位年龄分别为42岁和26岁、干性皮肤的受试者在使用前和使用90天后眼周皮肤状况的对比图,(a)为42岁试用者使用前;(b)为42岁试用者使用90天后;(c)为26岁试用者使用前;(d)为26岁试用者使用90天后。Figure 4 is a comparison chart of the skin conditions around the eyes of two subjects aged 42 and 26 years old with dry skin before use and after 90 days of use, (a) is before use by a 42-year-old trial person; (b) After 90 days of use by a 42-year-old trial person; (c) before use by a 26-year-old trial person; (d) after 90 days of use by a 26-year-old trial person.
具体实施方式detailed description
实施例1Example 1
一种眼霜,其特征在于所述眼霜的配方为:A kind of eye cream, it is characterized in that the prescription of described eye cream is:
一种眼霜的制备方法,包括以下步骤:A preparation method of eye cream, comprising the following steps:
将A相和B相分别置于70-75℃水浴锅中搅拌25-30min,使固状物溶解,再将溶解好的F相加入到A相中使其分散均匀,然后边搅拌边把B相加入;Put phase A and phase B in a water bath at 70-75°C and stir for 25-30 minutes to dissolve the solids, then add the dissolved phase F to phase A to disperse evenly, and then dissolve phase B while stirring phase join;
快速搅拌25-30min后降温,冷却至40-45℃时将C相、D相及E相分别加入并搅拌至均匀,温度降至30-35℃时停止搅拌,出料,即得所述眼霜。After rapid stirring for 25-30 minutes, cool down. When cooled to 40-45°C, add phase C, phase D, and phase E respectively and stir until uniform. When the temperature drops to 30-35°C, stop stirring and discharge to obtain the eye cream. .
性能测试:Performance Testing:
粒度测试Granularity test
取少量眼霜样品于载玻片上,盖上盖玻片,碾压均匀后置于显微镜下观察并拍照。显微镜放大倍数为400倍。Take a small amount of eye cream sample on a glass slide, cover it with a cover glass, roll it evenly, put it under a microscope to observe and take pictures. The microscope magnification is 400 times.
抗氧化测试Antioxidant test
称取0.5g眼霜,用纯水溶解后转入100mL容量瓶中定容,配制出质量浓度为5.00×10-3g/mL的样品溶液。Weigh 0.5g of eye cream, dissolve it in pure water, transfer it to a 100mL volumetric flask, and prepare a sample solution with a mass concentration of 5.00×10 -3 g/mL.
分别配制浓度为2×10-4g/mL的DPPH的无水乙醇溶液、浓度为10mmol/L水杨酸的无水乙醇溶液、浓度为10mmol/L的FeSO4水溶液、浓度为8.8mmol/L的H2O2水溶液、pH为8.2的Tris-HCl缓冲溶液、浓度为10mmol/L的HCl溶液、浓度为5mmol/L的邻苯三酚溶液(以浓度为10mmol/L的HCl溶液为溶剂)。Prepare the absolute ethanol solution of DPPH with a concentration of 2×10 -4 g/mL, the absolute ethanol solution with a concentration of 10mmol/L salicylic acid, the aqueous solution of FeSO 4 with a concentration of 10mmol/L, and a concentration of 8.8mmol/L H 2 O 2 aqueous solution, a Tris-HCl buffer solution with a pH of 8.2, a HCl solution with a concentration of 10mmol/L, and a pyrogallol solution with a concentration of 5mmol/L (the HCl solution with a concentration of 10mmol/L is used as a solvent) .
(1)对DPPH·自由基的抑制率测试(1) Test of the inhibition rate of DPPH free radicals
移取待测样品溶液3mL于10mL容量瓶中,随后加入3mL浓度为2×10-4g/mLDPPH溶液。盖上塞子,摇匀,反应30min,在517nm处测定吸光度Ai;测定3mL样液与3mL乙醇混合液的吸光度Aj;测定3mL浓度为2×10-4g/mLDPPH溶液与3mL纯水混合后的吸光度A0。根据公式P=[1-(Ai-Aj)/A0]×100%,将测得的吸光度带入求得待测液对DPPH·自由基的抑制率。Pipette 3mL of the sample solution to be tested into a 10mL volumetric flask, and then add 3mL of DPPH solution with a concentration of 2×10 -4 g/mL. Cover the stopper, shake well, react for 30 minutes, measure the absorbance A i at 517nm; measure the absorbance A j of the mixture of 3mL sample solution and 3mL ethanol; measure the concentration of 3mL 2×10 -4 g/mLDPPH solution mixed with 3mL pure water After absorbance A 0 . According to the formula P=[1-(A i -A j )/A 0 ]×100%, the measured absorbance is brought into to obtain the inhibition rate of the test solution on DPPH·free radicals.
(2)对·OH自由基的抑制率测试(2) Test of the inhibition rate of OH free radicals
向10mL的容量瓶中加入10mmol/L的水杨酸溶液和10mmol/L的FeSO4溶液各2mL,然后加入待测液2mL,再加入2mL浓度为8.8mmol/L的H2O2溶液,摇匀后于37℃水浴中反应30min。在510nm处测定吸光度Ai;以2mL纯水代替H2O2测定吸光度Aj;用2mL纯水代替待测液来测定吸光度A0。根据公式P=[1-(Ai-Aj)/A0]×100%,将测得的吸光度带入求得待测液对·OH自由基的抑制率。Add 2mL of 10mmol/L salicylic acid solution and 10mmol/L FeSO4 solution to a 10mL volumetric flask, then add 2mL of the test solution, then add 2mL of H2O2 solution with a concentration of 8.8mmol /L, shake After homogenization, react in a 37°C water bath for 30 minutes. Measure the absorbance A i at 510nm; measure the absorbance A j with 2mL pure water instead of H 2 O 2 ; measure the absorbance A 0 with 2mL pure water instead of the test solution. According to the formula P=[1-(A i -A j )/A 0 ]×100%, the measured absorbance is taken into the test solution to obtain the inhibition rate of OH free radicals.
(3)对·O2 -自由基的抑制率测试(3) Test of the inhibition rate of O 2 -free radicals
取pH为8.2的Tris-HCl缓冲溶液5mL于10mL容量瓶中,在25℃水浴中预热20min,然后依次加入待测液2mL和5mmol/L的邻苯三酚溶液0.5mL,立即摇匀,于25℃水浴中反应4min,立即在320nm处测定其吸光度Ai;以10mmol/L的HCl溶液0.5mL代替邻苯三酚,测定吸光度Aj;用2mL纯水代替待测液来测定吸光度A0。根据公式P=[1-(Ai-Aj)/A0]×100%,将测得的吸光度带入求得待测液对·O2 -自由基的抑制率。Take 5 mL of Tris-HCl buffer solution with a pH of 8.2 in a 10 mL volumetric flask, preheat it in a 25°C water bath for 20 min, then add 2 mL of the test solution and 0.5 mL of pyrogallol solution at 5 mmol/L in sequence, and shake well immediately. React in a water bath at 25°C for 4 minutes, and immediately measure the absorbance A i at 320nm; replace pyrogallol with 0.5mL of 10mmol/L HCl solution, and measure the absorbance Aj ; use 2mL pure water instead of the test solution to measure the absorbance A 0 . According to the formula P=[1-(A i -A j )/A 0 ]×100%, the measured absorbance is taken into account to obtain the inhibition rate of the test solution on ·O 2 -free radicals.
吸湿率测试Moisture Absorption Test
称取眼霜样品5g置于称量瓶中,在(20±1)℃、相对湿度在43%、75%的环境中放置,每隔1h取出称量一次,至8h。按下列公式计算吸湿率。Weigh 5g of the eye cream sample and place it in a weighing bottle, place it in an environment of (20±1)°C and a relative humidity of 43% and 75%, take it out and weigh it every 1h, up to 8h. Calculate the moisture absorption rate according to the following formula.
其中mn为放置n小时后样品质量,g;m0为放置前待测样品质量,g。Among them, m n is the mass of the sample after being placed for n hours, g; m 0 is the mass of the sample to be tested before being placed, in g.
感官性能评定Sensory performance evaluation
制备出的眼霜在室温和非阳光直射下目测观察膏体是否细腻,色泽是否均匀一致,用嗅觉鉴别气味是否纯正。The prepared eye cream is visually observed at room temperature and under non-direct sunlight to see whether the paste is fine and smooth, whether the color is uniform, and whether the smell is pure or not is identified by the sense of smell.
pH测试pH test
称取样品3.0g,放入盛有30.0mL除去CO2的去离子水的小烧杯中,加热至40±1℃并不断搅拌,冷至室温后用校正好的pH计测量。Weigh 3.0g of the sample, put it into a small beaker filled with 30.0mL of deionized water to remove CO2 , heat to 40±1°C with constant stirring, and measure it with a calibrated pH meter after cooling to room temperature.
高、低温实验High and low temperature experiments
将样品装入密封塑料盒中,分别置于40℃的恒温烘箱和-10℃的冰箱冷冻室中24h,取出恢复至室温后观察是否有油水分离现象或明显性状差异。Put the sample into a sealed plastic box, and place it in a constant temperature oven at 40°C and in a freezer at -10°C for 24 hours, take it out and return it to room temperature, and observe whether there is oil-water separation or obvious difference in properties.
功效测试efficacy test
选择20人作为测试人员,平均年龄为35周岁,多为干燥缺水性肤质。受试人员每天早晚于洁面后在眼周涂抹眼霜,共使用90天,每隔15天用皮肤测试仪测试一次皮肤状况。并对其中几位受试者在使用眼霜前和使用15分钟及30分钟后的眼部进行拍照。Select 20 people as testers, the average age is 35 years old, most of them have dry and dehydrated skin. The subjects applied eye cream around the eyes after cleansing every morning and evening for a total of 90 days, and tested their skin condition with a skin tester every 15 days. And the eyes of several subjects were photographed before using the eye cream and after 15 minutes and 30 minutes.
测试结果Test Results
乳化颗粒测试结果Emulsion particle test results
从图1可以看出,该眼霜样品的颗粒小且分散均匀,说明乳化效果好。通常在乳化剂固定的前提下,调整甘油、丁二醇、戊二醇比例为4:2:1时,制备出的眼霜分散相粒度最为均匀,膏体最为细腻。It can be seen from Figure 1 that the particles of the eye cream sample are small and evenly dispersed, indicating that the emulsification effect is good. Usually, under the premise of fixing the emulsifier and adjusting the ratio of glycerin, butanediol and pentylene glycol to 4:2:1, the particle size of the dispersed phase of the prepared eye cream is the most uniform, and the paste is the most delicate.
抗氧化测试结果Antioxidant Test Results
表2眼霜溶液对3种自由基的抑制率The inhibitory rate of table 2 eye cream solution to 3 kinds of free radicals
表2为眼霜溶液对3种自由基的抑制率。可以看出在浓度为5.00×10-3g/mL时,眼霜溶液对DPPH·、·OH和·O2 -3种自由基的抑制率分别达到了84.9%、63.6%和53.6%,表明本发明眼霜有较强的抗氧化能力,能有效清除自由基。较强的抗氧化能力主要是通过将抗氧化网络体系与白藜芦醇、乳香提取物、红景天提取物等复配所获得。Table 2 is the inhibition rate of eye cream solution to 3 kinds of free radicals. It can be seen that when the concentration is 5.00×10 -3 g/mL, the inhibition rate of the eye cream solution to DPPH·, ·OH and ·O 2 -3 free radicals reached 84.9%, 63.6% and 53.6%, respectively, indicating that this Invented eye cream has strong antioxidant capacity and can effectively scavenge free radicals. The strong antioxidant capacity is mainly obtained by compounding the antioxidant network system with resveratrol, frankincense extract, rhodiola extract, etc.
保湿性能分析Moisture Performance Analysis
以时间为横坐标、吸湿率为纵坐标作图,眼霜样品的吸湿率随时间变化的关系图见图2。图中可以看出吸湿率均为负值,说明较长时间放置样品都会失水;但由于样品中添加了多种保湿剂,在20℃,相对湿度分别为75%和43%的环境中放置8h后,吸湿率分别为-1.04%和-1.15%,失水非常缓慢,说明该眼霜具有较好的保湿能力。Taking time as the abscissa and the moisture absorption rate as the ordinate, the relationship diagram of the moisture absorption rate of the eye cream sample with time is shown in Figure 2. It can be seen from the figure that the moisture absorption rate is negative, indicating that the samples will lose water if they are left for a long time; however, since a variety of humectants are added to the samples, they should be placed in environments with relative humidity of 75% and 43% at 20°C After 8 hours, the moisture absorption rates were -1.04% and -1.15%, respectively, and the water loss was very slow, indicating that the eye cream has a good moisturizing ability.
感官及理化测试结果Sensory and physical and chemical test results
表3感官及理化指标测试结果Table 3 Sensory and physical and chemical index test results
表3的测试结果表明本发明眼霜的感官及理化指标均符合我国化妆品行业的标准要求。The test results in Table 3 show that the sensory and physical and chemical indicators of the eye cream of the present invention all meet the standard requirements of my country's cosmetics industry.
试用结果分析Analysis of Trial Results
图3是一位年龄为55岁、干性皮肤的试用者在使用眼霜前和使用15分钟、30分钟后的眼周皮肤拍照对比图。从图中可以看出,使用前眼周皮肤纹路较深,皱纹明显;使用本发明眼霜15分钟后,皱纹明显变浅,受试者能明显感觉到皮肤提拉感;使用30分钟后,皮肤纹路持续变浅,受试者依然能感觉到提拉效果。Figure 3 is a photo comparison of the skin around the eyes of a 55-year-old tester with dry skin before using the eye cream and after 15 minutes and 30 minutes. It can be seen from the figure that the lines of the skin around the eyes are deep and the wrinkles are obvious before use; after using the eye cream of the present invention for 15 minutes, the wrinkles are obviously lighter, and the subject can obviously feel the skin lifting feeling; after 30 minutes of use, the skin The lines continued to lighten, and the subject could still feel the lifting effect.
图4为其中两位年龄分别为42岁和26岁、干性皮肤的受试者在使用前和使用90天后眼周皮肤状况的对比图,其眼周皮肤各项指标变化情况见表4。可以看出,连续使用该眼霜90天后的眼周皮肤纹理明显变浅,缺水及眼周皮肤黯沉问题有所改善,眼周轮廓变得紧致。Figure 4 is a comparison of the skin conditions around the eyes of two subjects aged 42 and 26 years old with dry skin before use and after 90 days of use. The changes in various indicators of the skin around the eyes are shown in Table 4. It can be seen that after using the eye cream continuously for 90 days, the texture of the skin around the eyes becomes significantly lighter, the problems of dehydration and dull skin around the eyes are improved, and the contours of the eyes become firmer.
表4使用眼霜90天前后眼周皮肤各指标变化情况Table 4 Changes in various indicators of the skin around the eyes before and after using the eye cream for 90 days
。 .
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310561265.4A CN103599062B (en) | 2013-11-12 | 2013-11-12 | A kind of eye cream and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310561265.4A CN103599062B (en) | 2013-11-12 | 2013-11-12 | A kind of eye cream and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103599062A CN103599062A (en) | 2014-02-26 |
CN103599062B true CN103599062B (en) | 2016-05-25 |
Family
ID=50117371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310561265.4A Active CN103599062B (en) | 2013-11-12 | 2013-11-12 | A kind of eye cream and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103599062B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705414B (en) * | 2013-12-12 | 2016-01-20 | 诺斯贝尔化妆品股份有限公司 | A kind of eye cream |
CN104027269B (en) * | 2014-06-17 | 2016-09-07 | 娇时日化(杭州)股份有限公司 | Eye cream and preparation method thereof |
GB201423273D0 (en) * | 2014-12-26 | 2015-02-11 | Shang Chen Mei Bang Beijing Biolog Technology Co Ltd | The composite for eye care and its preparation method |
CN104546543A (en) * | 2015-01-09 | 2015-04-29 | 杭州四林生物科技有限公司 | tea polyphenol containing anti-wrinkling and skin-moistening eye cream and preparation process thereof |
CN105943475A (en) * | 2016-07-08 | 2016-09-21 | 广州花出见生物科技有限公司 | Wrinkle-relieving eye cream containing traditional Chinese medicine components as well as preparation method and application thereof |
CN105997841A (en) * | 2016-08-08 | 2016-10-12 | 黄美风 | Beauty maintenance eye cream and preparation method thereof |
CN106491460B (en) * | 2016-12-23 | 2019-09-27 | 广州市科能化妆品科研有限公司 | A kind of eye essence and preparation method thereof |
CN107375145B (en) * | 2017-08-09 | 2020-10-16 | 广州丸美生物科技有限公司 | Cosmetic matrix, preparation method and application thereof, eye cream and preparation method thereof |
CN107661262A (en) * | 2017-10-28 | 2018-02-06 | 安徽孔氏奇医药科技有限公司 | One kind is compacted radioresistance eye cream and preparation method thereof |
CN110522713B (en) * | 2019-08-14 | 2022-04-12 | 天津科技大学 | Milk-based liposome eye cream capable of resisting wrinkles, removing fat particles and blacking eyes and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102078283B (en) * | 2011-01-25 | 2012-03-28 | 朱爱民 | Whitening and freckle-removing nutrient cream of traditional Chinese medicine |
-
2013
- 2013-11-12 CN CN201310561265.4A patent/CN103599062B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN103599062A (en) | 2014-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103599062B (en) | A kind of eye cream and preparation method thereof | |
CN103585096B (en) | A kind of face of living essence and preparation method thereof that compacts | |
CN103393581B (en) | Natural anti-wrinkling anti-aging skin care composition and application thereof in cosmetic | |
CN104352418A (en) | An Anti-Aging Serum | |
CN103860453B (en) | A kind of face of living is compacted emollient cream and preparation method thereof | |
CN104352385A (en) | anti aging serum | |
CN106551870A (en) | A kind of compositionss with crease-resistant skin lightening effect, facial film and preparation method thereof | |
CN108125809A (en) | A kind of oxidation resistant cosmetic composition and preparation method thereof | |
CN107049896A (en) | Stem of noble dendrobium multiple-effect stoste and preparation method thereof | |
CN103767969B (en) | A kind of hand lotion obtained by effective constituent in Pericarpium Musae and its preparation method | |
CN103417466B (en) | Natural moisture-preserving and skin-protecting composition and application thereof in cosmetics | |
CN104622778A (en) | A kind of shower gel and preparation method thereof | |
CN104352382A (en) | Essence | |
CN105708759B (en) | A kind of pure natural anti-oxidant whitening multiple-effect washing cream containing peony seed oil and preparation method thereof | |
CN104546621A (en) | Anti-aging skincare composition and preparation method thereof | |
CN103494719A (en) | A kind of anti-aging facial cream and preparation method thereof | |
CN110292543B (en) | Biological composition for replacing ultraviolet absorbent and application thereof | |
JP6232180B2 (en) | Composition for mitigating skin irritation comprising ume plum extract | |
CN104188859B (en) | A kind of crease-resistant skin care emulsion containing natural component extract and preparation method thereof | |
CN101978942B (en) | Omega-3 fatty acid oil skin care lotion and preparation method thereof | |
CN104352384A (en) | Serum with anti-aging benefits | |
CN101401779A (en) | Cosmetic composition containing composite plant polyphenol extract and method of preparing the same | |
CN103006477A (en) | Camellia oil emollient cream | |
CN105943427A (en) | Multiple-effect moisturizing eye cream containing peony seed oil and preparation method thereof | |
CN105456124A (en) | Grape seed whitening mask |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 237009 Anhui Lu'an Economic Development Zone Science and Technology Innovation Service Center Co-patentee after: ANHUI University Patentee after: Anhui Dan Dan materia medica Technology Co.,Ltd. Address before: 237009 Anhui Lu'an Economic Development Zone Science and Technology Innovation Service Center Co-patentee before: Anhui University Patentee before: LU'AN DANHUANG BIOTECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230821 Address after: No. 716, 7th floor, building 4, No. 99, Guangfu Road, Wuhou District, Chengdu, Sichuan 610041 Patentee after: Chengdu yishenrui Technology Co.,Ltd. Address before: 237009 Anhui Lu'an Economic Development Zone Science and Technology Innovation Service Center Patentee before: Anhui Dan Dan materia medica Technology Co.,Ltd. Patentee before: ANHUI University Effective date of registration: 20230821 Address after: Room 1103, Unit 2, Building 7, Xiangyi Huafu, Huajian Road, Zhanggong District, Ganzhou, Jiangxi Province 341000 Patentee after: Zhao Xianliang Address before: No. 716, 7th floor, building 4, No. 99, Guangfu Road, Wuhou District, Chengdu, Sichuan 610041 Patentee before: Chengdu yishenrui Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |